Association of IL28B Polymorphism with Fibrosis, Liver Inflammation, Gender Respective Natural History of Hepatitis C Virus in Egyptian Patients with Genotype 4

被引:6
|
作者
Youssef, Samar Samir [1 ]
Abbas, Eman Abd El-Razek [1 ]
Abd el Aal, Asmaa Mostafa [1 ]
el Zanaty, Taher [2 ]
Seif, Sameh Mohamed [3 ]
机构
[1] Natl Res Ctr, Microbial Biotechnol Dept, Cairo 11231, Egypt
[2] Cairo Univ, Fac Med, Dept Internal Med, Cairo, Egypt
[3] Natl Hepatol & Trop Med Res Inst, Cairo, Egypt
来源
关键词
GENETIC-VARIATION; SPONTANEOUS CLEARANCE; PROGRESSION; INFECTION; THERAPY; SUSCEPTIBILITY;
D O I
10.1089/jir.2013.0036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The polymorphism of interleukin 28B (IL28B) rs12979860 is associated with spontaneous and treatment-induced clearance in hepatitis C virus (HCV) genotype 4 (G4). However, there is no information on its interaction with gender, moreover its association with intrahepatic inflammation in North Africans is not studied and its association with fibrosis in North Africans (especially Egyptians) is controversial. This study aims to explore the association between the minor allele of the IL28B rs12979860 polymorphism with gender, fibrosis and necroinflammation in Egyptian G4 HCV patients. IL28B rs12979860 was genotyped in 224 individuals, including 100 healthy controls and 124 consecutive patients with chronic HCV. Results showed (1) IL28B rs12979860 minor alleles associated with susceptibity to chronic HCV mainly in men not women, (2) no association between IL28B rs12979860 with fibrosis and necroinflammation activity, (3) the IL28B rs12979860 TT genotype associated with severe fibrosis in women only and with the necroinflammation activity in men using a recessive model. In conclusion, the IL28B rs12979860 polymorphism is not associated with fibrosis and liver inflammation in Egyptian HCV G4. Nonetheless, the TT genotype of IL28B rs12979860 polymorphism affects the natural history of each gender independently.
引用
收藏
页码:22 / 27
页数:6
相关论文
共 50 条
  • [41] Recipient IL28B Gene Polymorphism and Recurrent Hepatitis C Following Liver Transplantation in Romanian Patients
    Iacob, Speranta
    Iacob, Razvan
    Nastase, Anca
    Coriu, Daniel
    Paslaru, Liliana
    Popescu, Irinel
    Gheorghe, Liana
    LIVER TRANSPLANTATION, 2012, 18 : S247 - S247
  • [42] The Effect of IL28B Gene Polymorphism on Treatment Response in Iranian Patients with Hepatitis C Virus Infection
    Zare, Fateme
    Hadinedoushan, Hossein
    Meybodi, Mohsen Akhondi
    Dehghanmanshadi, Mahdi
    Bafghi, Seyyed Ali Mirghanizade
    Vakili, Mahmood
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2016, 9 (12) : 1 - 6
  • [43] IL28B polymorphism and genetic biomarkers of viral clearance in hepatitis C virus infection
    Holmes, Jacinta A.
    Sievert, William
    Thompson, Alexander J.
    BIOMARKERS IN MEDICINE, 2011, 5 (04) : 461 - 478
  • [44] FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C IS NOT INFLUENCED BY IL28B POLYMORPHISMS
    Aghemo, A.
    Marabita, F.
    De Nicola, S.
    Rumi, M. G.
    Cheroni, C.
    Scavelli, R.
    Crimi, M.
    Soffredini, R.
    Abrignani, S.
    De Francesco, R.
    Colombo, M.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S519 - S519
  • [45] Fibrosis progression in patients with chronic hepatitis C is not influenced by IL28B polymorphisms
    Aghemo, A.
    Marabita, F.
    De Nicola, S.
    Rumi, M. G.
    Cheroni, C.
    Scavelli, R.
    Crimi, M.
    Soffredini, R.
    Abrignani, S.
    De Francesco, R.
    Colombo, M.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S88 - S88
  • [46] EFFECT OF IL28B VARIATION ON PROGRESSION OF LIVER FIBROSIS AND HEPATOCARCINOGENESIS IN CHRONIC HEPATITIS C
    Asahina, Yasuhiro
    Tsuchiya, Kaoru
    Suzuki, Yuichiro
    Tamaki, Nobuharu
    Yasui, Yutaka
    Katoh, Tomoji
    Hosokawa, Takanori
    Ueda, Ken
    Nakanishi, Hiroyuki
    Itakura, Jun
    Kurosaki, Masayuki
    Izumi, Namiki
    HEPATOLOGY, 2011, 54 : 1361A - 1362A
  • [47] IL28B polymorphisms predict the virological response to standard therapy in patients with chronic hepatitis C virus genotype 4 infection
    Ayman A. Abdo
    Mohammed N. Al-Ahdal
    Saira S. Khalid
    Ahmed Helmy
    Faisal M. Sanai
    Khalid Alswat
    Waleed Al-hamoudi
    Safiyya M. Ali
    Hamad I. Al-Ashgar
    Abdallah Al-Mdani
    Ali Albenmousa
    Faleh Z. Al Faleh
    Mashael Al-Anazi
    Nisreen Khalaf
    Ahmed Al-Qahtani
    Hepatology International, 2013, 7 : 533 - 538
  • [48] IMPACT OF IL28B POLYMORPHISM ON TREATMENT DURATION IN HCV GENOTYPE 1 AND 4 PATIENTS
    Scherzer, Thomas-Matthias
    Staettermayer, Albert
    Kessler, Harald H.
    Gschwantler, Michael
    Strasser, Michael P.
    Laferl, Hermann
    Maieron, Andreas
    Stauber, Rudolf E.
    Datz, Christian
    Rutter, Karoline
    Beinhardt, Sandra
    Steindl-Munda, Petra E.
    Hofer, Harald
    Ferenci, Peter
    HEPATOLOGY, 2010, 52 (04) : 765A - 765A
  • [49] IL28B polymorphisms predict the virological response to standard therapy in patients with chronic hepatitis C virus genotype 4 infection
    Abdo, Ayman A.
    Al-Ahdal, Mohammed N.
    Khalid, Saira S.
    Helmy, Ahmed
    Sanai, Faisal M.
    Alswat, Khalid
    Al-hamoudi, Waleed
    Ali, Safiyya M.
    Al-Ashgar, Hamad I.
    Al-Mdani, Abdallah
    Albenmousa, Ali
    Al Faleh, Faleh Z.
    Al-Anazi, Mashael
    Khalaf, Nisreen
    Al-Qahtani, Ahmed
    HEPATOLOGY INTERNATIONAL, 2013, 7 (02) : 533 - 538
  • [50] Prediction of response to pegylated interferon plus ribavirin by IL28B gene variation in patients with hepatitis C virus genotype 4
    Shiha, Gamal
    Samir, Waleed
    Seif, Seham
    El-Etreby, Shahira A.
    Abdel-Khalek, Ehab
    HEPATOLOGY, 2012, 56 : 1023A - 1023A